<p>纽约，2025 年 12 月 26 日（全球新闻稿）—— LifeMD, Inc.（纳斯达克：LFMD），一家领先的虚拟初级医疗服务和药房解决方案提供商，今天宣布其董事会已授权向公司 8.875% 系列 A 累积永久优先股（纳斯达克：LFMDP）的持有人支付现金股息，每股金额为 0.5546875 美元。</p>
<p>优先股息将于 2026 年 1 月 15 日支付给截至 2026 年 1 月 5 日营业结束时的登记持有人。</p>
<p><strong>关于 LifeMD, Inc.</strong></p>
<p>LifeMD®是领先的虚拟初级医疗提供商。LifeMD 提供远程医疗、实验室和药房服务的访问，以及针对 200 多种疾病的专业治疗，涵盖初级医疗、男性和女性健康、体重管理和激素治疗。该公司利用垂直整合的专有数字护理平台、覆盖 50 个州的附属医疗集团、先进的附属配药药房以及美国本土的患者护理中心，以增加高质量和可负担护理的获取。有关更多信息，请访问 LifeMD.com。</p>
<p><strong>关于前瞻性声明的警示说明</strong></p>
<p>本新闻稿包含根据 1933 年证券法第 27A 条、1934 年证券交易法第 21E 条及 1995 年美国私人证券诉讼改革法的安全港条款的前瞻性声明。新闻稿中包含的前瞻性声明可以通过使用诸如 “相信”、“期望”、“预期”、“项目”、“应该”、“计划”、“将”、“可能”、“打算”、“估计”、“预测”、“继续” 和 “潜在” 等词语来识别，或在每种情况下，其否定形式或其他变体或参考未来时期的可比术语。前瞻性声明的示例包括但不限于关于我们财务前景和指导、短期和长期业务表现和运营、未来收入和收益、监管发展、法律事件或结果、遵守复杂和不断变化的法规的能力、市场条件和趋势、新或扩展的产品和服务、增长策略、基本假设，以及上述任何因素对我们未来经营结果或财务状况的影响的声明。</p>
<p>前瞻性声明不是历史事实，也不是对未来表现的保证。这些声明基于我们对未来计划和策略、预测、预期和未预期事件和趋势、经济以及其他未来条件的当前期望、信念和假设，包括上述任何因素对我们未来业务的影响。由于前瞻性声明涉及未来，因此它们受到固有风险、不确定性和难以预测的情况和假设变化的影响，其中一些超出我们的控制。因此，我们的实际结果、表现和财务状况可能与前瞻性声明中所指示的有重大差异。这些风险和不确定性包括但不限于我们向证券交易委员会提交的文件中识别的 “风险因素”，包括但不限于我们最近提交的 10-K 表格年度报告、10-Q 表格季度报告及其任何修正案。即使我们的实际结果、表现或财务状况与此类文件中包含的前瞻性声明一致，它们也可能不代表我们在后续期间的实际结果、表现或财务状况。</p>
<p>本新闻稿中所作的任何前瞻性声明均基于截至本声明发布之日我们当前可获得的信息。我们没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，除非适用法律或法规要求。</p>
<p><strong>投资者联系</strong></p>
<p>首席财务官 Marc Benathen</p>
<p>marc@lifemd.com</p>
<p><strong>媒体联系</strong></p>
<p>首席营销和产品官 Jessica Friedeman</p>
<p>press@lifemd.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05UUXlPU00zTXpNeE5ERTNJekl3TVRrek5UYz0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05UUXlPU00zTXpNeE5ERTNJekl3TVRrek5UYz0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png"/></p>

LFMD

<p>LifeMD, Inc. 宣布将为其 8.875% A 系列累积永久优先股支付每股 $0.5546875 的季度现金股息，股息将于 2026 年 1 月 15 日支付给截至 2026 年 1 月 5 日的股东</p>

<p>NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.</p>
<div class="lb-trans"><p>纽约，2025 年 12 月 26 日（全球新闻稿）—— LifeMD, Inc.（纳斯达克：LFMD），一家领先的虚拟初级医疗服务和药房解决方案提供商，今天宣布其董事会已授权向公司 8.875% 系列 A 累积永久优先股（纳斯达克：LFMDP）的持有人支付现金股息，每股金额为 0.5546875 美元。</p>
</div><p>The preferred dividend will be paid on January 15, 2026, to holders of record at the close of business on January 5, 2026.</p>
<div class="lb-trans"><p>优先股息将于 2026 年 1 月 15 日支付给截至 2026 年 1 月 5 日营业结束时的登记持有人。</p>
</div><p><strong>About LifeMD, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 LifeMD, Inc.</strong></p>
</div><p>LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, spanning primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.</p>
<div class="lb-trans"><p>LifeMD®是领先的虚拟初级医疗提供商。LifeMD 提供远程医疗、实验室和药房服务的访问，以及针对 200 多种疾病的专业治疗，涵盖初级医疗、男性和女性健康、体重管理和激素治疗。该公司利用垂直整合的专有数字护理平台、覆盖 50 个州的附属医疗集团、先进的附属配药药房以及美国本土的患者护理中心，以增加高质量和可负担护理的获取。有关更多信息，请访问 LifeMD.com。</p>
</div><p><strong>Cautionary Note Regarding Forward Looking Statements</strong></p>
<div class="lb-trans"><p><strong>关于前瞻性声明的警示说明</strong></p>
</div><p>This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1933 年证券法第 27A 条、1934 年证券交易法第 21E 条及 1995 年美国私人证券诉讼改革法的安全港条款的前瞻性声明。新闻稿中包含的前瞻性声明可以通过使用诸如 “相信”、“期望”、“预期”、“项目”、“应该”、“计划”、“将”、“可能”、“打算”、“估计”、“预测”、“继续” 和 “潜在” 等词语来识别，或在每种情况下，其否定形式或其他变体或参考未来时期的可比术语。前瞻性声明的示例包括但不限于关于我们财务前景和指导、短期和长期业务表现和运营、未来收入和收益、监管发展、法律事件或结果、遵守复杂和不断变化的法规的能力、市场条件和趋势、新或扩展的产品和服务、增长策略、基本假设，以及上述任何因素对我们未来经营结果或财务状况的影响的声明。</p>
</div><p>Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.</p>
<div class="lb-trans"><p>前瞻性声明不是历史事实，也不是对未来表现的保证。这些声明基于我们对未来计划和策略、预测、预期和未预期事件和趋势、经济以及其他未来条件的当前期望、信念和假设，包括上述任何因素对我们未来业务的影响。由于前瞻性声明涉及未来，因此它们受到固有风险、不确定性和难以预测的情况和假设变化的影响，其中一些超出我们的控制。因此，我们的实际结果、表现和财务状况可能与前瞻性声明中所指示的有重大差异。这些风险和不确定性包括但不限于我们向证券交易委员会提交的文件中识别的 “风险因素”，包括但不限于我们最近提交的 10-K 表格年度报告、10-Q 表格季度报告及其任何修正案。即使我们的实际结果、表现或财务状况与此类文件中包含的前瞻性声明一致，它们也可能不代表我们在后续期间的实际结果、表现或财务状况。</p>
</div><p>Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.</p>
<div class="lb-trans"><p>本新闻稿中所作的任何前瞻性声明均基于截至本声明发布之日我们当前可获得的信息。我们没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，除非适用法律或法规要求。</p>
</div><p><strong>Investor Contact</strong></p>
<div class="lb-trans"><p><strong>投资者联系</strong></p>
</div><p>Marc Benathen, Chief Financial Officer</p>
<div class="lb-trans"><p>首席财务官 Marc Benathen</p>
</div><p>marc@lifemd.com</p>
<div class="lb-trans"><p>marc@lifemd.com</p>
</div><p><strong>Media Contact</strong></p>
<div class="lb-trans"><p><strong>媒体联系</strong></p>
</div><p>Jessica Friedeman, Chief Marketing and Product Officer</p>
<div class="lb-trans"><p>首席营销和产品官 Jessica Friedeman</p>
</div><p>press@lifemd.com</p>
<div class="lb-trans"><p>press@lifemd.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05UUXlPU00zTXpNeE5ERTNJekl3TVRrek5UYz0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYwNTQyOSM3MzMxNDE3IzIwMTkzNTc="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/NWFiYzAwOTMtYjg5Yy00ZDNiLTk1OGYtOWZlMWU2NjUwYzFiLTEwMzA5MzAtMjAyNS0xMi0yNi1lbg==/tiny/LifeMD-Inc-.png"/></p>

LifeMD 宣布对 A 系列累积永久优先股进行季度股息分配 | LFMD 股票新闻